Biodegradable, non-toxic biological adhesive and methods for use in abdominal surgery
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61K-009/10
A61K-031/718
A61K-031/715
A61K-031/70
A61K-033/30
출원번호
US-0453468
(2012-04-23)
등록번호
US-8440227
(2013-05-14)
발명자
/ 주소
Cueto-Garcia, Jorge
출원인 / 주소
Cueto-Garcia, Jorge
대리인 / 주소
Michal, Esq., Robert P.
인용정보
피인용 횟수 :
1인용 특허 :
15
초록▼
A biological adhesive formulation comprising dextrin, at least one adhesiveness modifier agent, and at least one antibiotic is suitable for promoting healing of tissue in a patient, for example, to prevent anastomosis of a surgical wound in the digestive system of a patient, and for affixing prosthe
A biological adhesive formulation comprising dextrin, at least one adhesiveness modifier agent, and at least one antibiotic is suitable for promoting healing of tissue in a patient, for example, to prevent anastomosis of a surgical wound in the digestive system of a patient, and for affixing prosthesis during a hernia operation in a patient and occluding a fistula within a patient.
대표청구항▼
1. A method for promoting healing of tissue in a patient comprising applying to said tissue an adhesive formulation comprising dextrin as a dispersion, at least one adhesiveness modifier agent comprising from 8 weight % to about 19 weight % zinc oxide powder based on the total weight of the formulat
1. A method for promoting healing of tissue in a patient comprising applying to said tissue an adhesive formulation comprising dextrin as a dispersion, at least one adhesiveness modifier agent comprising from 8 weight % to about 19 weight % zinc oxide powder based on the total weight of the formulation, and optionally at least one antibiotic, wherein said formulation contains 80-97 weight % of said dextrin dispersion, and said dextrin dispersion contains 45-75 weight % solids, based on the total weight of the formulation, wherein said formulation has a viscosity of 12,000-25,000 cp, wherein said formulation protects and seals anastomosis and suture lines in internal body cavities, and having a resistance to humidity to provide temporary protection of the anastomosis from at least the 2nd to the 14th post-operative days. 2. A method for preventing dehiscence of an anastomosis or of a surgical wound in a patient, comprising applying to said anastomosis or surgical wound an adhesive formulation comprising dextrin as a dispersion, at least one adhesiveness modifier agent comprising from 8 weight % to about 19 weight % zinc oxide powder based on the total weight of the formulation, and optionally at least one antibiotic, wherein said formulation contains 80-97 weight % of said dextrin dispersion, and said dextrin dispersion contains 45-75 weight % solids, based on the total weight of the formulation, wherein said formulation has a viscosity of 12,000-25,000 cp, wherein said formulation protects and seals anastomosis and suture lines in internal body cavities, and having a resistance to humidity to provide temporary protection of the anastomosis from at least the 2nd to the 14th post-operative days. 3. A method according to claim 2, wherein said surgical wound is within the digestive system and said adhesive formulation protects against dehiscences of anastomosis of the digestive system. 4. A method of affixing a prosthesis during a hernia operation in a patient, comprising applying to said prosthesis an adhesive formulation comprising dextrin as a dispersion, at least one adhesiveness modifier agent comprising from 8 weight % to about 19 weight % zinc oxide powder based on the total weight of the formulation, and optionally at least one antibiotic, wherein said formulation contains 80-97 weight % of said dextrin dispersion, and said dextrin dispersion contains 45-75 weight % solids, based on the total weight of the formulation, wherein said formulation has a viscosity of 12,000-25,000 cp. 5. A method according to claim 4, wherein said hernia operation is for an inguinal hernia. 6. A method for occluding a fistula within a patient comprising applying to said fistula an adhesive formulation comprising dextrin as a dispersion, at least one adhesiveness modifier agent comprising from 8 weight % to about 19 weight % zinc oxide powder based on the total weight of the formulation, and optionally at least one antibiotic, wherein said formulation contains 80-97 weight % of said dextrin dispersion, and said dextrin dispersion contains 45-75 weight % solids, based on the total weight of the formulation, wherein said formulation has a viscosity of 12,000-25,000 cp.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (15)
Constancis Alain (Lyons FRX) Soula Grard (Meyzieu FRX) Tayot Jean-Louis (La Tour de Salvagny FRX) Tiollier Jrme (Lyons FRX), Adhesive compositions for surgical use.
Silvetti ; Sr. Anthony N. (930 Ashland Ave. River Forest IL 60305) Silvetti ; Jr. Anthony N. (930 Ashland Ave. River Forest IL 60305), Fructose containing wound healing preparation.
Santos Camila A. ; Jacob Jules S. ; Hertzog Benjamin A. ; Carino Gerardo P. ; Mathiowitz Edith, Methods and compositions for enhancing the bioadhesive properties of polymers using organic excipients.
Santos Camila A. ; Jacob Jules S. ; Hertzog Benjamin A. ; Carino Gerardo P. ; Mathiowitz Edith, Methods and compositions for enhancing the bioadhesive properties of polymers using organic excipients.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.